Establishment Registration
and Product Listing for Manufacturers of Human Blood and Blood
Products and Licensed Devices
Extension without change of a currently approved collection
No
Regular
06/28/2024
Requested
Previously Approved
36 Months From Approved
07/31/2024
2,722
2,966
1,460
1,496
0
0
The information collection supports
statutory requirements under the Federal Food, Drug, and Cosmetic
Act governing the registration of blood establishments and the
listing of blood products. The information obtained through this
collection registration assists FDA with its mandate to inspect
facilities and helps to ensure protection of the public health and
safety of the nation's blood supply.
US Code:
21 USC 301 et seq. Name of Law: Federal Food, Drug, and
Cosmetic Act
US Code: 42
USC 262 Name of Law: Public Health Service Act; Regulation of
biological products
The information collection
reflects agency adjustments. We have adjusted the currently
approved burden estimate we attribute to establishment registration
and product listing to reflect a decrease in product listing
updates and an increase in the number of initial registrations. Our
estimated burden for the information collection reflects an overall
decrease of 36 hours.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.